摘要:
Compounds of the general formula: {wherein X represents a group [in which R 3 represents a cycloalkyl or straight chain or branched alkyl group having up to 7 carbon atoms, said alkyl or cycloalkyl group optionally carrying 1 to 3 amino groups and/or 1 to 3 hydroxyl groups; a -(CH 2 ) n CO 2 R 4 group (in which n is the integer 1, 2 or 3, and R 4 represents a methyl or ethyl group); a pyridyl group; or a group of the formula: and R, and R 2 which may be the same or different, each represents a hydrogen atom or a methyl group, and indicates a or β bonding] possess good antibacterial and anti-tumor activity. The compounds of formula I may be prepared for example by reaction of mitomycin A, B, F or J with the appropriate amine.
摘要翻译:通式的化合物:其中X表示基[其中R 3表示具有至多7个碳原子的环烷基或直链或支链烷基,所述烷基或环烷基任选地含有1-3个氨基 基团和/或1至3个羟基; (CH 2)n CO 2 R 4基团(其中n为整数1,2或3,R 4表示甲基或乙基); 吡啶基; 或下式的基团:可以相同或不同的R 1和R 2各自表示氢原子或甲基,表示α或β键]具有良好的抗菌和抗肿瘤活性。 式I化合物可以例如通过丝裂霉素A,B,F或J与适当的胺反应来制备。
摘要:
7-N,8-N-ethylenemitomycin 8-imines represented by the formula wherein one of R₁ and R₂ represents carbamoyloxymethyl and another represents hydrogen or both are combined together to form methylene; R₃, R₄, R₅ and R₆ each independently represent hydrogen or C₁₋₄ alkyl, or R₃ and R₄ may be combined together to represent -(CH₂) n -, wherein n is 3 or 4; and Y and Z represent hydrogen or methyl, provided that when R₁ represents carbamoyloxymethyl and Y represents methyl, R₂, R₃, R₄, R₅, R₆ and Z are not hydrogen simultaneously, has an excellent antitumor activity.
摘要:
Disclosed are ski n-treatment products which comprise an enzyme-treated phospholipid, an aqueous phase component and an oily phase component. The skin-treatment products are safe, have high emulsification stability and excellent moisturizing effect and provide excellent feeling in use.
摘要:
Disclosed are ski n-treatment products which comprise an enzyme-treated phospholipid, an aqueous phase component and an oily phase component. The skin-treatment products are safe, have high emulsification stability and excellent moisturizing effect and provide excellent feeling in use.
摘要:
A fish growth hormone provided by a purified extract obtained from the pituitary gland of a fish belonging to salmonoid; the hormone is a polypeptide having the following physicochemical properties: (I) amino acid composition: as indicated in table 1; (II) the sequences of 33 amino acids at the N-terminal and 23 amino acids at the C-terminal are as follows: N-terminal: H 2 N-Ile-Glu-Asn-Gln-Arg-Leu-Phe-Asn-Ile-Ala-Val-Ser-Arg-Val-Gln-His-Leu-His-Leu-Leu-Ala-Gln-Lys-Met-Phe-Asn-Asp-Phe-Asp-Gly-Thr-Leu-Leu-C-terminal: -Met-His.Lys-Val-Glu-Thr-Tyr-Leu-Thr-Val-Ala-Lys-Cys-Arg-Lys-Ser-Leu-Glu-Ala-Asn-Cys-Thr-Leu-OH; (III) molecular weight: about 22,000; (IV) isoelectric point: 5.6-5.7; and (V) soluble in an alkaline aqueous solution and hardly soluble or insoluble in neutral and acidic aqueous solutions.
摘要:
A fish growth hormone provided by a purified extract obtained from the pituitary gland of a fish belonging to salmonoid; the hormone is a polypeptide having the following physicochemical properties:
(I) amino acid composition: as indicated in table 1; (II) the sequences of 33 amino acids at the N-terminal and 23 amino acids at the C-terminal are as follows:
N-terminal: H 2 N-Ile-Glu-Asn-Gln-Arg-Leu-Phe-Asn-Ile-Ala-Val-Ser-Arg-Val-Gln-His-Leu-His-Leu-Leu-Ala-Gln-Lys-Met-Phe-Asn-Asp-Phe-Asp-Gly-Thr-Leu-Leu-C-terminal: -Met-His.Lys-Val-Glu-Thr-Tyr-Leu-Thr-Val-Ala-Lys-Cys-Arg-Lys-Ser-Leu-Glu-Ala-Asn-Cys-Thr-Leu-OH;
(III) molecular weight: about 22,000; (IV) isoelectric point: 5.6-5.7; and (V) soluble in an alkaline aqueous solution and hardly soluble or insoluble in neutral and acidic aqueous solutions.
摘要:
A preventive and healing composition for disease due to lipoxygenase metabolic products, which comprises an effective amount of a compound represented by the formula: (wherein R is an alkyl group having 1-15 carbon atoms, Y is a hydrogen atom or a halogen atom, and X is a hydroxyl group when Y is a halogen atom and X is a hydroxyl group, a lower alkoxy group, a lower alkylthio group, a benzyloxy group or a benzylthio group when Y is a hydrogen atom) and at least one pharmaceutically acceptable carrier.